Investment Highlights - The pharmaceutical index did not record any positive returns across six sub-industries this week [1] - Under the backdrop of tightening ESG regulations, the pharmaceutical manufacturing industry is accelerating the integration of sustainable development into core strategies, with a significant increase in report disclosure rates [2][7] - The industry has fully entered the innovative drug phase, with R&D expenditure in 2023 reaching 33,278 billion, a year-on-year increase of 8.1% [10] - Companies like Haier Biomedical are breaking international monopolies through high R&D investments, establishing a global model [10] Industry Trends - Green transformation has become a new growth point in response to environmental pressures, with companies like Jiangzhong Pharmaceutical and Health元 Pharmaceutical implementing water recycling and wastewater management systems to avoid production suspension penalties and achieve cost reduction [2][10] - The importance of product quality and data security is highlighted, with MSCI assigning a weight of 27.1% to these issues in the pharmaceutical manufacturing sub-industry [11] - Companies such as Kanglong Chemical are utilizing AI technology to shorten R&D cycles, while Mindray Medical has established a zero-leakage information security system [11] Market Performance - The pharmaceutical sector's performance from March 16 to March 21 shows that the top two sub-industries with the highest decline were Traditional Chinese Medicine II (-1.16%) and Biological Products (-1.79%), while the lowest were Pharmaceutical Commerce (-4.01%) and Medical Services (-4.32%) [14] - The valuation levels for the pharmaceutical sector indicate that Biological Products had the highest PE ratio at 84.41 times, while Traditional Chinese Medicine II had the lowest at 28.90 times [14] Regulatory Developments - The first dedicated Medical Device Law is set to be included in the 2026 legislative agenda, establishing a comprehensive regulatory framework for the entire lifecycle of medical devices [22] - The new law aims to enhance regulatory compliance and international standard alignment, significantly reducing costs for companies looking to expand internationally [22] Industry Insights - The meeting between Minister Wang Wentao and Eli Lilly's CEO highlighted the ongoing commitment to enhancing Sino-US economic relations, with Eli Lilly planning to invest an additional 3 billion in China over the next decade [21] - The annual work summary meeting for Hunan's biopharmaceutical and medical device industry emphasized the region's potential as a new pillar industry, with significant advancements in R&D capabilities and investment outcomes [25]

Investment Rating - The industry rating is "Outperform the Market" [6][71] Core Insights - The report highlights significant developments in the lithium battery sector, with advancements in solid-state batteries from Chery and Yiwei Lithium Energy, indicating sustained optimism in the lithium battery market [2][10] - A landmark event in the photovoltaic sector is Tesla's plan to invest approximately $2.9 billion in Chinese photovoltaic equipment, aiming to establish a 100GW annual production capacity in the U.S. by the end of 2028, marking a pivotal moment for Chinese photovoltaic equipment companies [3][20][22] - In the wind power sector, the UK is set to accelerate the AR8 renewable energy contract allocation, while multiple regions in China are advancing offshore wind development goals under the "14th Five-Year Plan" [4][34][35] - The nuclear fusion industry is gaining strategic importance, with recent policy signals elevating its status within national development priorities, indicating a shift towards commercialization and ecosystem development [4][42][44] - The energy storage market is experiencing growth in EPC bidding and a new trading model in Guangxi, which enhances the profitability of storage assets [51][53] Summary by Sections 1. New Energy Vehicles and Lithium Battery Sector - Solid-state battery advancements from Chery and Yiwei Lithium Energy are noted, with Chery planning to expand its solid-state battery team significantly [10][11] - February saw a year-on-year increase in battery production and sales, with total production reaching 141.6GWh and sales at 113.2GWh [11] 2. New Energy Generation Sector 2.1 Photovoltaic Sector - Tesla's $2.9 billion order for Chinese photovoltaic equipment is a historic milestone, expected to reshape the global supply chain and enhance the profitability of Chinese manufacturers [20][22] - The report discusses price trends in the photovoltaic supply chain, with significant price drops in polysilicon and solar cells, indicating a challenging market environment [23][25] 2.2 Wind Power Sector - The UK is expediting the AR8 renewable energy contract allocation process, with expectations for multiple offshore wind projects to participate [34] - Domestic regions are setting ambitious offshore wind development targets, with Shandong and Jiangsu leading initiatives [35] 2.3 Nuclear Fusion Sector - The report emphasizes the strategic elevation of nuclear fusion within national policy, marking a transition towards a more structured industry development approach [42][44] 3. Energy Storage Sector - The energy storage market is seeing a significant increase in EPC bidding, with a notable rise in the scale of projects awarded [51][52] - Guangxi's new trading model for energy storage is highlighted as a breakthrough, enhancing the profitability of storage projects [53] 4. Power Equipment Sector - The report notes a substantial increase in fixed asset investment in power grids, with growth rates exceeding 80% for both State Grid and Southern Grid [60][61] - Key projects in high-voltage and distribution networks are advancing, providing clear visibility for orders in the equipment supply chain [61]

Group 1 - The report highlights that the intensity of AI investment in the US is high, but the sustainability of marginal returns is questionable. There is a possibility of external pressure being transferred to maintain the expansion path until a systemic correction occurs in the related bubble [2][3] - The process of maintaining AI valuations in the US may create a siphoning effect on global sovereign wealth, exacerbating the fragility of the global financial system. If energy prices continue to rise, the probability of the Federal Reserve restarting the interest rate hike cycle may increase [3] - In the context of rising global fragility, RMB assets may have relatively outstanding allocation value. It is suggested to focus on the two main lines of the RMB's phase appreciation and rising energy prices, and to conduct structural adjustments in the Chinese market on an annual basis [3] Group 2 - The report expresses a mid-term positive outlook on coal, new energy, agriculture, electricity, oil, and US capital goods related to inflation [3] - For the long term, the report favors insurance, central state-owned enterprises, anti-involution, and Chinese internet companies [3] Group 3 - The report indicates that the Federal Reserve maintains a positive outlook on the resilience of the US economy, raising the GDP growth forecast for 2026 from 2.3% to 2.4%. However, inflation concerns have significantly increased, with the overall PCE inflation forecast for 2026 raised from 2.4% to 2.7% [8][10] - The report notes that the US AI infrastructure expansion is driving capital expenditure growth, but the commercialization process is relatively lagging, raising doubts about the sustainability of marginal capital returns [9]

Investment Rating - The report does not explicitly state an investment rating for the industry Core Insights - The chemical sector has experienced significant volatility, with the CITIC Basic Chemical Index dropping by 9.49% and the Shenwan Chemical Index falling by 10.53% this week [2][13] - The report highlights the impact of geopolitical tensions, particularly the Iranian attack on Qatar, which has affected 17% of Qatar's liquefied natural gas export capacity, leading to an estimated annual revenue loss of approximately $20 billion [3] - The commencement of the first phase of Hengyi's coal-to-chemical fiber project, with an investment of 25.7 billion yuan, is noted as a significant development in the industry [3] Summary by Sections Market Performance - The Shanghai Composite Index decreased by 3.38%, while the ChiNext Index increased by 1.26% [2][13] - The top five sub-industries in terms of performance were polyester (-4.83%), paint and ink (-5.56%), rubber products (-5.88%), tires (-6.29%), and other plastic products (-6.52%) [2][16] - The bottom five sub-industries included phosphate and phosphorus chemicals (-16.22%), chlor-alkali (-12.89%), pesticides (-12.08%), soda ash (-11.43%), and potassium fertilizer (-11.39%) [2][16] Major Industry Developments - The Iranian attack on Qatar has led to a significant disruption in LNG production, with two out of 14 production lines damaged, resulting in a production interruption of 12.8 million tons annually for 3 to 5 years [3] - Hengyi Group's coal-to-chemical fiber project in Turpan, Xinjiang, is set to invest 150 billion yuan over 5 to 8 years, aiming to create a vertically integrated industrial cluster [3] Investment Themes - The tire sector is highlighted as having strong domestic competitiveness, with recommended companies including Sailun Tire, Senqcia, General Tire, and Linglong Tire [3] - The consumer electronics sector is expected to gradually recover, with a focus on upstream material companies benefiting from the recovery in the panel industry [4] - The report suggests attention to resilient cyclical industries and those that have completed inventory destocking, which may outperform the broader market in the coming year [4] Sub-Industry Insights - In the polyurethane sector, pure MDI prices remained stable at 22,300 yuan/ton, with operating rates at 73.5% [27] - The tire industry shows a slight increase in operating rates for both all-steel and semi-steel tires, indicating a stable demand environment [51] - The agricultural chemicals sector is experiencing price increases for glyphosate and other pesticides, driven by supply constraints and rising raw material costs [53][56]

Investment Rating - The industry rating is "Outperform the Market" [7][60]. Core Insights - The consumer market showed a steady recovery in January-February 2026, with total retail sales reaching 8.61 trillion yuan, a year-on-year increase of 2.8%, significantly accelerating from December 2025 [3][13]. - The rural market continues to outperform urban areas, confirming the judgment that rural consumption has a higher marginal propensity to consume and greater resilience [3][14]. - Swarovski's brand transformation is yielding results, with 2025 revenue of 1.969 billion euros, an organic growth of 6%, and EBITDA increasing by 12% [4][29]. - Samsonite's revenue for 2025 was 3.498 billion dollars, a slight decline of 2.5%, but showed signs of recovery in Q4 with positive growth in Asia, Europe, and Latin America [4][30]. Summary by Sections Consumer Market Performance - In January-February 2026, retail sales in urban areas grew by 2.7%, while rural areas saw a growth of 3.2%, indicating a 0.5 percentage point advantage for rural consumption [14]. - The share of county and rural retail sales in total retail sales reached 38.5%, up 0.1 percentage points from the previous year [14]. - Basic and optional upgrade consumption showed positive trends, with retail sales of essential goods growing significantly [23]. Company Performance - Swarovski's revenue growth was supported by a strong performance in direct sales and the North American market, with all regions and channels reporting growth [4][29]. - Samsonite's strategy to expand from traditional travel products to a broader lifestyle category is beginning to pay off, with improvements in direct retail sales [4][30]. Market Trends - The overall consumer recovery is not solely driven by subsidies but is supported by improved purchasing behavior, increased foot traffic, and festive activities [23]. - The demand for experience-oriented, upgraded, and smart green consumption continues to be a major highlight, with significant growth in service retail sales [28].

Investment Rating - The industry is rated as "Outperform" [5] Core Insights - Precious metals are under pressure due to rising inflation expectations and the Federal Reserve's decision to delay interest rate cuts, leading to a continued decline in gold prices [9][10] - Industrial metals, particularly copper, are facing downward pressure due to escalating geopolitical tensions and inflation warnings, resulting in significant price drops [12][13] - The lithium carbonate market is experiencing a price decline while maintaining low inventory levels, with a gradual recovery in production expected [18][21] - The tungsten market remains in a tight balance between supply and demand, with ongoing negotiations between buyers and sellers [22][23] Summary by Sections Precious Metals - Inflation expectations are rising, and the Federal Reserve has maintained interest rates, contributing to a downward trend in gold prices [9][10] - Gold prices have seen declines of approximately 10.49% to 10.57% across various markets [9] - Key stocks to watch include Zhaojin Mining, Zijin Mining, and others in both A-shares and H-shares [11] Industrial Metals - The copper market is under pressure due to geopolitical tensions and rising energy prices, leading to a significant drop in prices [12][13] - The price of copper has decreased by 5.6% this week, with concerns about supply disruptions [12] - Key stocks to monitor include Jiangxi Copper, Luoyang Molybdenum, and others [17] New Energy Metals - Lithium carbonate prices are declining, with production expected to recover steadily [18][21] - The demand for lithium remains strong, particularly in the energy storage sector, despite some market disruptions due to geopolitical issues [21] - Key stocks in this sector include Ganfeng Lithium and others [21] Other Minor Metals - The tungsten market is characterized by a tight supply-demand balance, with prices remaining stable amid ongoing negotiations [22][23] - The market is gradually shifting towards high-end and green transformation, with various segments showing differentiated development [23] - Key stocks to watch include Jinxin International Resources and others [23]

Investment Rating - The industry rating is "Outperform the Market" [7] Core Insights - The report highlights that the National Health Commission has revised the management measures for the National Essential Medicines List, indicating that a new list will be released soon, which is expected to boost the volume of newly included products [4][18]. - The report suggests that the Chinese medicine sector is currently undervalued and underrepresented, with potential for a turning point due to policy catalysts, falling raw material prices, and inventory clearance [4][20]. - The report emphasizes that the pharmaceutical sector has been under pressure, with the CITIC Pharmaceutical Index down 2.9% for the week and 2.7% year-to-date, underperforming the CSI 300 Index [3][26]. Summary by Sections Market Review - The CITIC Pharmaceutical Index fell by 2.9% from March 16 to March 20, 2026, underperforming the CSI 300 Index by 0.8 percentage points, ranking 10th among CITIC's primary industry classifications [3][26]. - The top five performing stocks during this period were *ST Jingfeng (+27.7%), Sanofi (+23.1%), Jieda Biological (+15.6%), Jiuan Medical (+12.7%), and Xinlitai (+10.9%) [3][44]. Policy and Market Opportunities - The upcoming revision of the essential medicines list is expected to clarify the implementation of the "986" policy, which mandates that a certain percentage of essential medicines be stocked in various healthcare institutions [20][24]. - The report recommends focusing on leading state-owned enterprises and brand-name Chinese medicine companies, as well as potential opportunities in the essential medicines list [4][20]. Investment Strategy - The report outlines a strategy for 2026, focusing on three main areas: innovative drugs, medical devices, and companies benefiting from domestic demand [5][4]. - Suggested stocks for investment include Kangfang Biotech, Innovent Biologics, WuXi AppTec, and Sanli Pharmaceutical [5][14]. Performance Metrics - The overall valuation of the pharmaceutical sector as of March 20, 2026, is 27.91, with a relative valuation premium of 2.93% compared to the broader A-share market [34][41]. - The total trading volume for the pharmaceutical sector during the week was 417.38 billion yuan, accounting for 3.8% of the total A-share trading volume [41][44].

1. Report Industry Investment Rating No information provided regarding the industry investment rating in the document. 2. Core Viewpoints of the Report - Despite increased external disturbances such as tax - period outflows and government bond net payments, the current liquidity remains loose, which may be due to cash inflows and fiscal expenditure. The central bank's attitude of maintaining a wait - and - see stance and downplaying the expectation of interest rate cuts also contributes to the loose liquidity environment. The probability of the central bank's systematic tightening is limited, especially at the end of the quarter, but potential fluctuations in the capital market after the quarter - end need to be monitored [5][50][53]. - The net payment of government bonds will increase next week, and there are multiple external disturbances. However, considering the central bank's strong willingness to maintain stable liquidity, the loose liquidity pattern is expected to continue [11][77][81]. - Forecasts for government bond issuance and net financing in March and the second quarter of 2026 are provided. It is estimated that the net financing of government bonds in March will be 1.07 trillion, and the cumulative net financing in the first quarter will be about 3.67 trillion. The cumulative net financing in the second quarter is expected to be about 3.6 trillion, slightly lower than the same period in 2025 [7][10][72]. 3. Summary According to the Directory 3.1 Money Market 3.1.1 This Week's Capital Review - The central bank's OMO had a net injection of 6.58 billion yuan this week. Despite tax - period outflows and over 30 billion yuan in government bond net payments, the capital remained loose. DR001 stayed at 1.32% for 5 consecutive days, and R007 dropped below 1.5% [3][16]. - The trading volume of pledged repurchase fluctuated within a narrow range, with the daily average trading volume decreasing by 0.2 trillion yuan to 8.37 trillion yuan compared to last week. The overall scale of pledged repurchase remained around 12 trillion yuan, slightly lower than last week. The net lending of large - scale banks decreased, while that of small and medium - sized banks increased. The net lending of non - banks had limited changes, with insurance and wealth management lending increasing, and other products and money market funds lending decreasing. The net borrowing of non - banks first decreased and then increased, generally lower than last week. The capital gap index also fluctuated within a narrow range, remaining at a relatively low level [4][25]. - The progress of cross - quarter capital in mid - to - early March was slow, and the gap compared to previous years widened after 14 - day funds could cross the quarter. As of the 20th, the cross - quarter progress of inter - bank institutions reached the lowest level in recent years; the cross - month progress of the exchange market was only slightly higher than that in 2022; the cross - month progress of the entire market was at a low of 7.0%, 3.9 percentage points lower than the historical average [31]. - The loose capital may be due to cash inflows and fiscal expenditure. The excess reserve ratio in February rose to 1.2%, and the broad fiscal deficit exceeded expectations by 15 billion yuan, leading to a larger - than - expected decrease in government deposits. Even if there is a net withdrawal of 50 billion yuan from OMO and MLF in March, the excess reserve ratio is still expected to reach 1.4% [5][42]. - The stability of DR001 at 1.32% for 6 trading days around the tax period may be related to the central bank's stability - maintenance. The central bank downplayed the expectation of interest rate cuts but maintained a loose environment to avoid potential impacts on the bond market [50][53]. 3.1.2 Next Week's Capital Outlook - This week, the net payment of government bonds was 30.63 billion yuan. Next week, the issuance of 7 - year treasury bonds will be 17.5 billion yuan, and assuming the 91 - day discounted treasury bonds are the same as the previous value, the total treasury bond issuance will be about 21.5 billion yuan. Thirteen regions will issue local bonds with a total scale of 30.86 billion yuan. Considering the 36 billion yuan of treasury bonds issued this Friday will be paid next week, the net payment of government bonds will rise to 60.64 billion yuan [54]. - The 7 - day reverse repurchase maturity scale will rise to 24.23 billion yuan next week, and there will be 45 billion yuan of MLF maturing on Wednesday. The net payment of government bonds will increase, mainly concentrated on Monday and Wednesday. Wednesday is also the reserve payment day. The online issuance of the new stock of Longyuan Co., Ltd. on the Beijing Stock Exchange is expected to have a certain impact on the exchange capital price from Monday to Tuesday. However, considering the central bank's strong willingness to maintain stable liquidity, the loose liquidity pattern is expected to continue [77][81]. 3.2 Inter - bank Certificates of Deposit - This week, the 1 - year Shibor rate decreased by 2.1 BP to 1.555% compared to March 13th. The secondary rate of 1 - year AAA - rated inter - bank certificates of deposit decreased by 1.75 BP to 1.515% [82]. - The issuance scale of inter - bank certificates of deposit decreased while the maturity scale increased. The net financing of state - owned banks, joint - stock banks, city commercial banks, and rural commercial banks was - 31.44 billion yuan, - 8.87 billion yuan, - 3.31 billion yuan, and 0.34 billion yuan respectively. The issuance proportion of 1 - year certificates of deposit decreased by 6 percentage points to 35%. Next week, the maturity scale of certificates of deposit will be about 69.93 billion yuan, a decrease of 47.39 billion yuan compared to this week [83]. - The issuance success rates of state - owned banks and joint - stock banks decreased, while those of city commercial banks and rural commercial banks increased, and all banks were around the average level in recent years. The issuance spread of 1 - year certificates of deposit between city commercial banks and joint - stock banks widened [87]. - The relative supply - demand strength index of certificates of deposit increased overall, with the willingness of money market funds to increase holdings in both the primary and secondary markets significantly enhanced. The demand from funds and wealth management products was relatively stable. The index increased by 6.3 percentage points to 29.1% throughout the week, in line with the seasonal pattern of recovery in March. Except for the 1 - month supply - demand index, the supply - demand indices of other maturities increased [98]. 3.3 Bill Market This week, bill interest rates decreased slightly. As of March 20th, the 3 - month and 6 - month bill interest rates of national - owned and joint - stock banks decreased by 5 BP and 6 BP respectively to 1.43% and 1.17% compared to March 13th [103]. 3.4 Bond Trading Sentiment Tracking - This week, the interest rate curve continued to steepen, and the spread of Tier 2 and perpetual bonds slightly narrowed. Large - scale banks generally tended to increase bond holdings, but their willingness to increase treasury bond holdings declined, especially for 10 - year treasury bonds. Their willingness to increase holdings of 1 - 3 - year and 7 - year treasury bonds and 7 - year policy - financial bonds increased, and their willingness to reduce holdings of Tier 2 and perpetual bonds and 1 - 3 - year policy - financial bonds decreased [105]. - The overall willingness of trading - type institutions to reduce bond holdings decreased. Securities companies' willingness to reduce holdings decreased, fund companies tended to increase holdings, and other institutions and products' willingness to increase holdings increased [105]. - The overall willingness of allocation - type institutions to increase bond holdings significantly decreased. Small and medium - sized banks tended to reduce holdings, and the willingness of insurance companies and wealth management products to increase holdings decreased [105].

Investment Rating - The report maintains an "Outperform" rating for the light industry sector [4]. Core Insights - Leshu Comfort's 2025 annual report slightly exceeded market expectations, with revenue of $567 million, a year-on-year increase of 24.9%, and a profit of $121 million, up 27.4% [3][10]. - Recent product launches from leading companies in the soft furniture sector, including Kuka Home and Minsun Holdings, indicate a trend towards smart product upgrades, suggesting a potential concentration of market share among top players [3]. - The light industry sector has recently experienced a pullback, with many companies' valuations returning to attractive levels, prompting recommendations to focus on stocks like Zhongxin Co., Jiu Long Paper, and Leshu Comfort [3]. Summary by Sections Home Furnishing - Kuka Home launched four smart flagship products, including the Hertz S9 smart sofa and the Moon Shadow M8 smart mattress, enhancing their AI capabilities [8]. - Kuka Home is also investing $160 million in a new production base in Indonesia, expected to generate an annual output value of approximately $220 million upon completion [8]. - The home furnishing sector's valuations and institutional holdings are at historical lows, with expectations for gradual improvement in fundamentals post-Q2 [8]. Paper Industry - As of March 20, 2026, prices for various paper types showed mixed trends, with double glue paper at 4,737.5 CNY/ton (+12.5 CNY), while white card paper decreased to 4,218 CNY/ton (-26 CNY) [8][52]. - Jiu Long Paper announced a price increase for April, maintaining a bullish outlook on paper prices supported by strong pulp prices [8]. - The paper industry is expected to see a recovery in prices due to strong support from wood pulp prices and a favorable exchange rate for imported pulp [8]. Packaging - Dazhengda announced an investment of 550 million CNY to acquire a stake in Chipton Semiconductor, enhancing its capabilities in high-performance graphics processing [10]. - The packaging sector is advised to focus on companies with stable operations and attractive dividend yields, such as Yutong Technology and Meiyingsen [10]. Export Chain - In the first two months of 2026, China's exports increased by 21.8% year-on-year, with trade with ASEAN and EU growing significantly [12]. - Recommendations for export chain companies include Zhongxin Co., Zhiou Technology, and others with strong production capabilities in the U.S. market [12]. Light Industry Consumption - Leshu Comfort's strategic expansion into Africa and Latin America, along with a 4%-7% increase in average selling prices, positions it well for future growth [12]. - The company reported a gross margin of 35.9%, benefiting from favorable currency exchange rates and product optimization [12].

行 业 研 究 煤炭 2026 年 03 月 21 日 内贸煤优势突出，煤价拾级而上 投资要点： 动力煤 行 业 定 期 报 告 截至 3 月 20 日，秦港 5500K 动力末煤平仓价 735 元/吨，周环比 +6 元/吨，内蒙古 5500K 产地价大涨，山西 5500K 产地价小涨，陕西 6000K 产地价大涨。截至 3 月 20 日，动力煤 462 家样本矿山日均产量 549.8 万吨，周环比+3.3 万吨，年同比-5%。本周电厂日耗大跌，电厂 库存小涨，动力煤库存指数大涨，秦港库存大涨，截至 3 月 16 日， 动力煤库存指数为 195.2。非电方面，甲醇、尿素开工率分别为 92.9%（+2.7pct）和 92.2%（-1.1pct），仍处于历史同期偏高水平。 焦煤 截至 3 月 20 日，京唐港主焦煤库提价 1620 元/吨，周环比+50 元/ 吨，山西产地价小涨，河南产地价持平、安徽产地价格持平。截至 3 月 20 日，523 家样本矿山精煤日均产量 79.8 万吨（+2.1 万吨），年 同比+8.3%，523 家样本矿山精煤库存 254.1 万吨（-23.6 万吨），年 同比-31.8%；截至 ...